A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in Laminoplasty

Sponsor
Kyunghee University Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06113497
Collaborator
(none)
60
2
23

Study Details

Study Description

Brief Summary

This study is the first prospective randomized controlled trial to analyze the effects and safety of multimodal cocktail injections after cervical laminoplasty

Condition or Disease Intervention/Treatment Phase
  • Drug: Cocktail injection
Phase 4

Detailed Description

This study is the first prospective randomized controlled trial to analyze the effects and safety of multimodal cocktail injections after cervical laminoplasty. Through this study, we anticipate that the potential usefulness of multimodal cocktail analgesic injections in various aspects of spinal surgery will be demonstrated, offering valuable insights and possibilities.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Supportive Care
Official Title:
A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in Laminoplasty
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Oct 24, 2024
Anticipated Study Completion Date :
Sep 30, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Group 1

The group that received normal saline 40ml injection into the deep fascia and muscular layer during wound closure.

Experimental: Group 2

The group that received cocktail therapy injection into the deep fascia and muscular layer during wound closure.

Drug: Cocktail injection
Morphine 5 mg, ropivacaine 150 mg, tramadol 40 mg, epinephrine 1 mg, ketorolac 60 mg, and ketamine 1 g will be mixed with normal saline to prepare a total volume of 60 ml
Other Names:
  • Normal saline injection
  • Outcome Measures

    Primary Outcome Measures

    1. Change from Baseline in Pain (VAS/Visual Analog Score) [Baseline and Post operation 7 days]

      A VAS score, also known as a Visual Analog Scale score, is a common method used in healthcare and research to measure subjective or self-reported sensations or experiences, such as pain, anxiety, mood, or other subjective states. It typically consists of a horizontal or vertical line, usually 10 centimeters in length, with anchor points at either end. One end is labeled with the most negative or extreme aspect of the sensation or experience being measured, and the other end is labeled with the most positive or least extreme aspect.

    2. Change from Baseline in function (JOA/Japanese Orthopaedic Association Score) score [Baseline and Post operation 7 days]

      The JOA score is often calculated based on a specific set of criteria and is used to help guide treatment decisions and monitor a patient's progress. It provides a standardized way to assess and communicate the clinical status of individuals with cervical myelopathy. The score may range from 0 (severe impairment) to 17 (normal function), with lower scores indicating greater disability.

    3. Change from Baseline in function (NDI/Neck Disability Index score) score [Baseline and Post operation 7 days]

      The NDI questionnaire typically consists of ten questions or items, and individuals are asked to rate their level of disability or limitation in various aspects of daily life due to neck pain. The questions cover a range of activities, including personal care, work, sleep, and recreational activities. Each question is scored on a scale from 0 to 5, with 0 indicating no disability and 5 indicating severe disability. The individual's responses to these questions are then totaled to calculate the NDI score, usually expressed as a percentage.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Diagnosed with cervical myelopathy or radiculopathy and scheduled to undergo laminoplasty

    • Recorded preoperative upper limb pain (Visual Analog Scale [- VAS] ), neck pain (VAS), Japanese Orthopaedic Association (JOA) scores, and Neck Disability Index (NDI) scores.

    • Adults aged 20 years and above, but below 80 years capable of articulating their own pain or functional abnormalities

    • Cognitive function at a level that enables them to comprehend and adhere to study procedures

    Exclusion Criteria:
    • Previous surgical treatment of the cervical spine.

    • Adolescents aged 20 years or below, pregnant individuals, or those with the potential for pregnancy.

    • Hypersensitivity reactions to mixed medications used in Cocktail therapy. (morphine 5 mg, ropiva 150 mg, tamceton 40 mg, epinephrine 1 mg, ketocin 60 mg, jetiam 1 g).

    • Patients who lack the capacity for medical consent or are unable to communicate effectively in a medical context.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Kyunghee University Medical Center

    Investigators

    • Study Chair: Kyung-Chung Kang, Associate Professor, Kyunghee University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kyung-Chung Kang, Associate Professor, Spine Center, Department of Orthopaedic Surgery, Kyunghee University Medical Center
    ClinicalTrials.gov Identifier:
    NCT06113497
    Other Study ID Numbers:
    • futurespine
    First Posted:
    Nov 2, 2023
    Last Update Posted:
    Nov 8, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 8, 2023